Immunology of Silicones pp 93-99 | Cite as
Cytotoxicity and Membrane Damage in vitro by Inclusion Complexes Between γ-Cyclodextrin and Siloxanes
Abstract
Inclusion complexes of γ-cyclodextrin and octamethylcyclotetrasiloxane (D4), decamethyltetrasiloxane (M10TS), and 1,3,5,7-tetramethyltetravinyIcyclotetra-siloxane (TMTV-D4) were prepared to compare the cytotoxic effects of siloxanes in vitro. In these preparations, the hydrophobic siloxanes are surrounded by a hydrophilic shell of eight circularly linked D-glucose molecules (γ-cyclodextrin), and upon contact with plasma membranes the siloxane molecule can intercalate into the lipid bilayer of the cell membrane. XRPC24, 2-11 plasmacytoma, CH12.LX lymphoma and P388D1 macrophage-like cells were used as indicator cells in toxicity assays. Using an MTT tetrazolium reduction to formazan test, a colorimetric method to determine the number of viable cells, the 50% minimal lethal doses (CD50) for the siloxane compounds were found to range from 30 to 50 μM. Sublethal doses (e.g., 15 μM and lower) resulted in the loss of lactate dehydrogenase (LDH) and glutathione (GSH) from the cytosolic compartment of the target cells and thus indicated cytotoxicity. Treatment of macrophages with siloxanes resulted in a higher production of interleukin-6 (IL-6) than was exhibited by untreated macrophages. The B9 cell bioassay of these treated cells showed as much as a 10 fold higher production (500 U/ml) of IL-6 than did the untreated cells. The degree of increase was dependent on the compound and concentration used. The results of this study show that low molecular weight siloxanes produce lethal effects on B-lymphocyte derived target cells in vitro and permeabilize the plasma membranes at lower sublethal concentrations.
Keywords
Inclusion Complex P38801 Cell Breast Implant Silicone Compound Silicone Breast ImplantPreview
Unable to display preview. Download preview PDF.
References
- Arkes B (1983) Look what you can make out of silicone. Chemtech 13:542–555Google Scholar
- Bridges AJ, Vasey FB (1993) Silicone breast implants. History, Safety, and potential Complications. Arch Intern Med 153:2639–2644CrossRefGoogle Scholar
- Kishimoto T (1989) The biology of interleukin 6. Blood 74:1–10PubMedGoogle Scholar
- Lacoste J, Israëli Y (1993) Photooxidation of silicones. Polymer reprints 33:(1) 127–128Google Scholar
- LeVier RR, Chandler ML, Wendel SR (1978) The pharmacology of silanes and siloxanes. In Biochemistry of silicon and related problems. Ed. Bendz G Lindquist I, Plenum Press, New York, pp 473–514Google Scholar
- Moav B, Horowitz M, Cohen JB, Rechavi G, Eliyahu E, Oren M, Givol D (1986) Gene 48:297–300PubMedCrossRefGoogle Scholar
- Nordan RP, Potter M (1986) A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science 233:566–569PubMedCrossRefGoogle Scholar
- Pitha J, Me T, Sklar P, Nye J (1988) Drug solubilizers to aid pharmacologists; amorphous cyclodextrin derivates. Life Sciences 43:493–502PubMedCrossRefGoogle Scholar
- Shacter E, Lopez RL, Beecham EJ, Janz S (1990) DNA damage induced by phorbol ester-stimulated neutrophils is augmented by extracellular cofactors. Role of histidine and metals. J Biol Chem 265:6693–6699PubMedGoogle Scholar
- Shacter E, Arzadon GK, Williams J (1992) Elevation of interleukin-6 in response to a chronic inflammatory stimulus in mice: Inhibiton by indomethacin. Blood 80:194–202PubMedGoogle Scholar
- Szejtli J (1989) Downstream processing using cyclodextrins. TIBTECH 7:170–174Google Scholar
- Tietze F (1969) Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Analyt Biochem 27:502–522PubMedCrossRefGoogle Scholar
- Wakatsuki Y, Strober W (1993) Effects of downregulation of germline transcripts on immunoglobulin a isotope differentiation. J Exp Med 178:129–138PubMedCrossRefGoogle Scholar